In March 2014, Neodent USA launched its line of ‘Drive CM’ dental implants in the US. Nobel Biocare says these implants have striking similarities to the design of the NobelActive® implants which were launched in 2008. Further, Nobel Biocare asserts that Neodent USA has relied on Nobel Biocare’s history of successful clinical data in marketing the Neodent product.
Both US patents asserted in the lawsuit relate to technology for aiding the surgical installation and successful integration of the implants in a variety of patient bone types.
Richard Laube, Nobel Biocare’s CEO, said: “We are committed to enforce our valuable intellectual property rights, which are the result of our industry-leading investment in R&D. We will not tolerate copies of our unique and patented dental implant designs.”
“The preliminary design of NobelActive® was invented and developed by an Israeli team at AlphaBioTec Ltd – not originally by Nobel Biocare, as many people believe. We did our homework before launching our range of implants in the US, especially the Drive CM, and we are confident that we have not infringed any patents”, said Tony Susino, CEO of Neodent USA. “In its media release, Nobel Biocare has sent a clear signal to the dental community that our implant is ‘strikingly similar’ to theirs. Nobel sees that we have a very attractive, high quality alternative.”
Pictured: Neodent USA's Drive CM implant